Exact unit markings depend on your specific compound, so follow your provider's direction
The ADA 2026 Standards of Care now recommend GLP-1 receptor agonists with demonstrated cardiovascular benefit for patients with type 2 diabetes and established ASCVD, multiple cardiovascular risk factors, or chronic kidney disease, and note that combination with SGLT2 inhibitors may provide additive benefit
Damilakis, J., Adams, J
Mounjaro is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 diabetes mellitus treatment The mechanism behind taste alterations remains unclear but may relate to effects on gastric emptying, blood glucose fluctuations, or gastrointestinal symptoms Taste changes are generally temporary and tend to resolve as the body adjusts to treatment Contact your GP if taste disturbances persist beyond 46 weeks, significantly affect nutrition, or are accompanied by concerning symptoms such as severe abdominal pain or oral lesions Table of Contents Why Does Mounjaro Cause a Sweet Taste in Your Mouth
We work on a contingency fee basis you only pay if we win compensation for you
Dosage Each vial is 1ml, containing 1,000 mcgs (We also offer a 2ml vial
